StageZero Life Sciences Ltd T.SZLS

RE:RE:RE:RE:We at StageZero Life Sciences want to assure

[FacBine]

Tough mosquito , take your complaints here: Company Contacts: James R. Howard-Tripp Chairman & CEO [e-mail] Tel: [phone] Ext. 1 Rebecca Greco Investor Relations [e-mail] Tel: [phone] Ext. 1838

KPOIndustries wrote:

Listen FacBine, I've lost a f$ckload on this company over false promises. I'm just asking legitimate questions. Everyone here is so defensive on criticism, why? Because deep down you know it's risky and it smells like this isn't all adding up. We as investors have been promised a lot and all we've gotten in the last 6 months is news on more and more financing. No updates on Benalux, no updates on telehealth, underachieving financials. So why bul$hit anymore? Let's get truth and fact in here and stop pumping bull$hit up everyone's a$$. Where are the facts? Does anyone have anything new and factual about SZLS in the past 6 months?

FacBine wrote: @KPOIndustries, here's something for you to read: https://messageboardfools.com/bashers.htm

KPOIndustries wrote:

Has anyone been to the lab? Does it exist? Is Tripp in a closet with a beaker and that's deemed to be a "lab"? The Richmond Hill office is a virtual office, no mention about that eh?

 

FacBine wrote:
We at StageZero Life Sciences want to assure our clients and shareholders that we are monitoring the coronavirus (COVID-19) situation closely. Our lab is currently open, and we are enacting safety measures around COVID-19. We will continue to monitor the situation and respond as appropriate. Should any shareholders be concerned you may reach out to us via [e-mail]. About StageZero Life Sciences, Ltd. StageZero Life Sciences is dedicated to the early detection of cancer and multiple disease states through whole blood. Aristotle, our next generation test, is a panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform which has been validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer, with further validation currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com. Company Contacts: James R. Howard-Tripp Chairman & CEO [e-mail] Tel: [phone] Ext. 1 Rebecca Greco Investor Relations [e-mail] Tel: [phone] Ext. 1838 More at: https://www.stagezerolifesciences.com/